EBS Cash & Equivalents
Emergent Biosolutions Inc · Cash & Equivalents
EBS Cash & Equivalents
Latest reported$205.40Mperiod ending
EBS FY Cash & Equivalents ($5.85M → $205.40M)
Annual Cash & Equivalents
High-resolution chart · PNG
EBS cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 205,400,000 | |
| 99,500,000 | |
| 111,700,000 | |
| 642,600,000 | |
| 576,300,000 | |
| 621,300,000 | |
| 168,000,000 | |
| 112,200,000 | |
| 178,292,000 | |
| 271,513,000 | |
| 312,795,000 | |
| 280,499,000 | |
| 179,338,000 | |
| 141,666,000 | |
| 143,901,000 | |
| 169,019,000 | |
| 102,924,000 | |
| 91,473,000 | |
| 105,730,000 | |
| 76,418,000 | |
| 36,294,000 | |
| 6,821,000 | |
| 4,891,000 | |
| 5,854,000 |